- Home
- INDP vs CWD Comparison
INDP vs CWD Comparison
Compare INDP & CWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- CWD
- Stock Information
- Founded
- INDP 2000
- CWD 2009
- Country
- INDP United States
- CWD United States
- Employees
- INDP N/A
- CWD N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- CWD Real Estate
- Sector
- INDP Health Care
- CWD Finance
- Exchange
- INDP Nasdaq
- CWD Nasdaq
- Market Cap
- INDP 10.2M
- CWD 10.0M
- IPO Year
- INDP N/A
- CWD 2023
- Fundamental
- Price
- INDP $0.94
- CWD $0.50
- Analyst Decision
- INDP Strong Buy
- CWD
- Analyst Count
- INDP 2
- CWD 0
- Target Price
- INDP $8.50
- CWD N/A
- AVG Volume (30 Days)
- INDP 24.7K
- CWD 70.9K
- Earning Date
- INDP 11-12-2024
- CWD 11-12-2024
- Dividend Yield
- INDP N/A
- CWD N/A
- EPS Growth
- INDP N/A
- CWD N/A
- EPS
- INDP N/A
- CWD N/A
- Revenue
- INDP N/A
- CWD $66,376,999.00
- Revenue This Year
- INDP N/A
- CWD N/A
- Revenue Next Year
- INDP N/A
- CWD $38.91
- P/E Ratio
- INDP N/A
- CWD N/A
- Revenue Growth
- INDP N/A
- CWD N/A
- 52 Week Low
- INDP $0.84
- CWD $0.37
- 52 Week High
- INDP $3.10
- CWD $1.50
- Technical
- Relative Strength Index (RSI)
- INDP 34.68
- CWD 46.43
- Support Level
- INDP $0.94
- CWD $0.44
- Resistance Level
- INDP $1.06
- CWD $0.52
- Average True Range (ATR)
- INDP 0.05
- CWD 0.03
- MACD
- INDP 0.00
- CWD 0.01
- Stochastic Oscillator
- INDP 0.00
- CWD 79.38
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About CWD CaliberCos Inc.
CaliberCos Inc is an asset management firm, whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. Majority of revenue is derived from Asset management fees segment.